Tempus AI (NASDAQ:TEM) Stock Price Down 0% on Insider Selling

Tempus AI, Inc. (NASDAQ:TEM)’s stock price fell 0% during trading on Thursday after an insider sold shares in the company. The stock traded as low as $47.12 and last traded at $48.02. 3,016,581 shares were traded during trading, a decline of 40% from the average session volume of 5,007,310 shares. The stock had previously closed at $48.03.

Specifically, Director David R. Epstein sold 990 shares of the firm’s stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $46.83, for a total value of $46,361.70. Following the sale, the director now owns 26,284 shares in the company, valued at approximately $1,230,879.72. This trade represents a 3.63 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Andrew Polovin sold 13,135 shares of the stock in a transaction that occurred on Tuesday, March 18th. The shares were sold at an average price of $45.98, for a total transaction of $603,947.30. Following the completion of the transaction, the executive vice president now owns 154,171 shares of the company’s stock, valued at $7,088,782.58. This trade represents a 7.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In other news, CFO James William Rogers sold 23,030 shares of the stock in a transaction that occurred on Tuesday, March 18th. The shares were sold at an average price of $45.97, for a total value of $1,058,689.10. Following the completion of the transaction, the chief financial officer now directly owns 164,750 shares in the company, valued at $7,573,557.50. This trade represents a 12.26 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.

Analyst Ratings Changes

Several research analysts have recently issued reports on TEM shares. TD Cowen reiterated a “buy” rating and issued a $74.00 price objective (up from $58.00) on shares of Tempus AI in a report on Wednesday, February 5th. Piper Sandler decreased their price objective on shares of Tempus AI from $70.00 to $55.00 and set a “neutral” rating for the company in a report on Tuesday, March 4th. Needham & Company LLC increased their price objective on shares of Tempus AI from $56.00 to $70.00 and gave the company a “buy” rating in a report on Tuesday, February 25th. William Blair reiterated a “market perform” rating on shares of Tempus AI in a report on Tuesday, February 25th. Finally, Bank of America increased their price objective on shares of Tempus AI from $54.00 to $60.00 and gave the company a “neutral” rating in a report on Monday, March 3rd. Six research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to MarketBeat.com, Tempus AI currently has an average rating of “Moderate Buy” and an average price target of $61.18.

Tempus AI Price Performance

The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55. The company’s 50-day moving average is $56.07 and its 200 day moving average is $51.45.

Institutional Investors Weigh In On Tempus AI

Several hedge funds have recently made changes to their positions in TEM. Wells Fargo & Company MN lifted its position in Tempus AI by 13.2% in the 4th quarter. Wells Fargo & Company MN now owns 2,384 shares of the company’s stock worth $80,000 after buying an additional 278 shares in the last quarter. First Horizon Advisors Inc. acquired a new position in Tempus AI in the 3rd quarter valued at $30,000. Geode Capital Management LLC grew its stake in Tempus AI by 0.4% in the 3rd quarter. Geode Capital Management LLC now owns 133,171 shares of the company’s stock valued at $7,537,000 after buying an additional 539 shares during the last quarter. Operose Advisors LLC acquired a new stake in Tempus AI in the 4th quarter worth $25,000. Finally, Prestige Wealth Management Group LLC grew its position in Tempus AI by 910.4% in the 4th quarter. Prestige Wealth Management Group LLC now owns 1,071 shares of the company’s stock worth $36,000 after purchasing an additional 965 shares during the last quarter. Hedge funds and other institutional investors own 24.22% of the company’s stock.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.